Valgen Co 80/12,5 mg; 160/12,5 mg; 160/25 mg; 320/12,5 mg; 320/25 mg FC tablets
PDF Leaflet Revision Date: 03 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension.
Dosage (summary)
1 tablet daily; adjust based on individual components.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to components
- Severe renal impairment
- Angioedema history
Common side effects
- Dizziness
- Hypotension
- Fatigue
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any skin lesions
Serious warnings
- Risk of angioedema
- Monitor potassium levels
Important Disclaimer
The Valgen Co 80/12,5 mg; 160/12,5 mg; 160/25 mg; 320/12,5 mg; 320/25 mg FC tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
